Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$782,676
-$160,162 QoQ
Shares Held
6,195
-8.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,182
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $61,483,180 across 10 Drug Manufacturers - General names. GILD ranks #10 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,397 | $29,262,496 | |
| 2 | ABBV |
AbbVie Inc.
|
45,639 | $11,484,597 | |
| 3 | JNJ |
Johnson & Johnson
|
28,586 | $7,259,986 | |
| 4 | AMGN |
Amgen Inc
|
16,862 | $6,106,067 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,615 | $2,135,027 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
25,296 | $1,457,555 | |
| 7 | NVO |
Novo Nordisk A S
|
25,368 | $1,216,141 | |
| 8 | PFE |
Pfizer Inc
|
38,365 | $923,829 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $782,676 | 6,195 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $942,838 | 6,765 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $914,167 | 7,448 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $750,360 | 6,760 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $801,590 | 7,230 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $729,333 | 6,509 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $611,766 | 6,623 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $614,714 | 7,332 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $565,826 | 8,247 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,424,355 | 33,097 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $2,695,040 | 33,268 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,350,867 | 31,370 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,414,834 | 31,333 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,592,895 | 31,251 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,930,489 | 34,135 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $2,517,692 | 40,812 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,991,899 | 80,762 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,759,031 | 80,051 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $5,918,804 | 81,515 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,247,271 | 75,122 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,215,869 | 75,746 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,955,440 | 76,674 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,413,544 | 75,756 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,602,425 | 88,660 | Shares | Defined | 2020-12-14 | |
| 2020-06-30 | $6,941,372 | 90,218 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,155,514 | 82,337 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||